Vaktsina "Gam-Kovid-Vak" was more popular than serums from AstraZeneca plc and Moderna to Czech Republic

The preference to the Russian preparation is given by every seventh inhabitant Czech Republic, results of survey which was conducted by agencies CVVM and Median testify. The preparation created by the Russian scientists to Czech Republic, was more popular than competitors from Moderna, AstraZeneca plc and Sinopharm. Let's notice that Vaktsina "Gam-Kovid-Vak" does not extend yet to Czech Republic...